Showing results (181-190 of 228) with videos related to
Sort By:
Pageof 23
Clinical and Experimental Immunology|April 1, 1978
The immunogloblin nature of nephritic factor (NeF)D M Scott, N Amos, J G Sissons, et al.Clinical and Experimental Immunology|September 1, 1992
C7 M/N protein polymorphism typing applied to inherited deficiencies of human complement proteins C6 and C7R Würzner, N Rance, P C Potter, et al.Clinical and Experimental Immunology|July 1, 1985
Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteasesP Woo, P J Lachmann, R A Harrison, et al.Complement (Basel, Switzerland)|January 1, 1987
Specificity of membrane complement receptor type three (CR3) for beta-glucansG D Ross, J A Cain, B L Myones, et al.The Journal of General Virology|September 1, 1990
The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigensD Davis, B Chaudhri, D M Stephens, et al.Clinical and Experimental Immunology|March 1, 1990
Peptide inhibitors of C3 breakdownP Peake, M Szelke, D M Jones, et al.Scandinavian Journal of Haematology|August 1, 1975
Lymphosarcoma, cold urticaria, IgG1 monoclonal cryoglobulin and complement abnormalitiesG Hauptmann, J M Lang, M L North, et al.The Journal of Biological Chemistry|March 10, 1985
A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbitsP D Hoeprich, C A Dahinden, P J Lachmann, et al.Complement (Basel, Switzerland)|January 1, 1988
Structure of C3f, a small peptide specifically released during inactivation of the third component of complementR A Harrison, T C Farries, F D Northrop, et al.Current Pharmaceutical Design|September 24, 2004
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeuticsP S Hiemstra, B A Fernie-King, J McMichael, et al.Pageof 23